IL125903A0 - Indole derivatives useful as endothelin receptor antagonists - Google Patents

Indole derivatives useful as endothelin receptor antagonists

Info

Publication number
IL125903A0
IL125903A0 IL12590397A IL12590397A IL125903A0 IL 125903 A0 IL125903 A0 IL 125903A0 IL 12590397 A IL12590397 A IL 12590397A IL 12590397 A IL12590397 A IL 12590397A IL 125903 A0 IL125903 A0 IL 125903A0
Authority
IL
Israel
Prior art keywords
receptor antagonists
indole derivatives
endothelin receptor
derivatives useful
useful
Prior art date
Application number
IL12590397A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL125903A0 publication Critical patent/IL125903A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL12590397A 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists IL125903A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
IL125903A0 true IL125903A0 (en) 1999-04-11

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12590397A IL125903A0 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Country Status (43)

Country Link
US (4) US6017945A (id)
EP (1) EP0901470B1 (id)
JP (1) JP3245179B2 (id)
KR (1) KR100331217B1 (id)
CN (1) CN1124262C (id)
AP (1) AP830A (id)
AR (1) AR007030A1 (id)
AT (1) ATE263151T1 (id)
AU (1) AU717849B2 (id)
BG (1) BG102873A (id)
BR (1) BR9709072A (id)
CA (1) CA2253876A1 (id)
CO (1) CO4650036A1 (id)
CZ (1) CZ292928B6 (id)
DE (1) DE69728392T2 (id)
DK (1) DK0901470T3 (id)
DZ (1) DZ2227A1 (id)
EA (1) EA001471B1 (id)
ES (1) ES2218675T3 (id)
GB (1) GB9609641D0 (id)
HK (1) HK1019149A1 (id)
HN (1) HN1997000058A (id)
HR (1) HRP970249B1 (id)
HU (1) HUP9901245A3 (id)
ID (1) ID16878A (id)
IL (1) IL125903A0 (id)
IS (1) IS1856B (id)
MA (1) MA26428A1 (id)
NO (1) NO312547B1 (id)
NZ (1) NZ332640A (id)
OA (1) OA10896A (id)
PE (1) PE65098A1 (id)
PL (1) PL329725A1 (id)
PT (1) PT901470E (id)
SI (1) SI0901470T1 (id)
SK (1) SK150398A3 (id)
TN (1) TNSN97078A1 (id)
TR (1) TR199802269T2 (id)
TW (1) TW491838B (id)
UA (1) UA50767C2 (id)
UY (1) UY24546A1 (id)
WO (1) WO1997043260A1 (id)
ZA (1) ZA973963B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
KR100838617B1 (ko) 1999-02-10 2008-06-16 아스트라제네카 아베 혈관형성 억제제로서의 퀴나졸린 유도체
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
DK1397130T3 (da) 2001-06-20 2007-11-12 Wyeth Corp Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
JP2006510673A (ja) 2002-12-10 2006-03-30 ワイス プラスミノゲンアクティベータインヒビター１（ｐａｉ−１）のインヒビターとしての、アリール、アリールオキシ、および、アルキルオキシ置換１ｈ−インドール−３−イルグリオキシル酸誘導体
US7348351B2 (en) 2002-12-10 2008-03-25 Wyeth Substituted 3-alkyl and 3-arylalkyl 1H-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
DE60306548T2 (de) 2002-12-10 2007-06-21 Wyeth Substituierte 3-carbonyl-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren
BR0316584A (pt) 2002-12-10 2005-10-04 Wyeth Corp Derivados de ácido acético indol oxo-acetil amino substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
BRPI0406883A (pt) * 2003-01-22 2006-01-03 Lilly Co Eli Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
WO2006023865A1 (en) 2004-08-23 2006-03-02 Wyeth Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
AU2006279496A1 (en) 2005-08-17 2007-02-22 Wyeth Substituted indoles and use thereof
KR20080111137A (ko) * 2006-04-13 2008-12-22 액테리온 파마슈티칼 리미티드 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
WO2020176599A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637355A (id) * 1962-09-14
GB1255518A (en) * 1968-10-08 1971-12-01 Sumitomo Chemical Co 2-indolylacetic acid derivatives and process for production thereof
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
EP0548250B1 (en) * 1990-09-10 1996-03-27 Rhone-Poulenc Rorer International (Holdings) Inc. Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
DK0617001T3 (da) * 1993-03-19 2000-04-17 Merck & Co Inc Phenoxyphenyleddikesyrederivater
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
ID16878A (id) 1997-11-20
NZ332640A (en) 2001-03-30
CZ292928B6 (cs) 2004-01-14
BR9709072A (pt) 1999-08-03
HUP9901245A2 (hu) 1999-08-30
TW491838B (en) 2002-06-21
CN1216531A (zh) 1999-05-12
NO985225L (no) 1998-11-09
EA199800908A1 (ru) 1999-06-24
US6017945A (en) 2000-01-25
JP3245179B2 (ja) 2002-01-07
KR100331217B1 (ko) 2002-05-09
SI0901470T1 (en) 2004-08-31
GB9609641D0 (en) 1996-07-10
IS1856B (is) 2003-02-21
WO1997043260A1 (en) 1997-11-20
PE65098A1 (es) 1998-10-29
CA2253876A1 (en) 1997-11-20
NO985225D0 (no) 1998-11-09
PT901470E (pt) 2004-07-30
IS4838A (is) 1998-08-28
EP0901470B1 (en) 2004-03-31
HK1019149A1 (en) 2000-01-14
JPH11508285A (ja) 1999-07-21
US6136843A (en) 2000-10-24
ATE263151T1 (de) 2004-04-15
CO4650036A1 (es) 1998-09-03
AR007030A1 (es) 1999-10-13
BG102873A (en) 1999-11-30
OA10896A (en) 2001-10-11
DE69728392D1 (de) 2004-05-06
ES2218675T3 (es) 2004-11-16
AU2697897A (en) 1997-12-05
US6306852B1 (en) 2001-10-23
UY24546A1 (es) 2000-09-29
EA001471B1 (ru) 2001-04-23
PL329725A1 (en) 1999-04-12
TNSN97078A1 (fr) 2005-03-15
DK0901470T3 (da) 2004-07-12
US6384070B2 (en) 2002-05-07
KR20000010879A (ko) 2000-02-25
HN1997000058A (es) 1997-06-26
HRP970249A2 (en) 1998-06-30
DZ2227A1 (fr) 2002-12-25
HRP970249B1 (en) 2003-06-30
DE69728392T2 (de) 2005-01-13
CN1124262C (zh) 2003-10-15
HUP9901245A3 (en) 2002-01-28
CZ358298A3 (cs) 1999-08-11
UA50767C2 (uk) 2002-11-15
TR199802269T2 (xx) 2001-12-21
EP0901470A1 (en) 1999-03-17
SK150398A3 (en) 1999-03-12
US20010014677A1 (en) 2001-08-16
NO312547B1 (no) 2002-05-27
AU717849B2 (en) 2000-04-06
MA26428A1 (fr) 2004-12-20
AP830A (en) 2000-05-03
AP9700982A0 (en) 1997-07-31
ZA973963B (en) 1998-11-09

Similar Documents

Publication Publication Date Title
IL125903A0 (en) Indole derivatives useful as endothelin receptor antagonists
AU4746297A (en) Vitronectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
GB9718913D0 (en) Substituted oxindole derivatives
HK1003883A1 (en) Indole derivatives as 5-ht receptor antagonist
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
IL123581A0 (en) Pyrimidine derivatives as 5HT2c- receptor antagonists
EP0885205A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HK1019744A1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
IL127417A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
AU8871898A (en) Phenylindole derivatives as 5-ht2a receptor antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU1150999A (en) Indole derivative useful as endothelin receptor antagonist
AU6826498A (en) Endotholin receptor antagonists
AU2943899A (en) Indole derivatives as 5-ht2a receptor antagonists
SI0912556T1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
EP0957908A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GB9811283D0 (en) Vironectin receptor antagonists
IL108842A0 (en) Benzylimidazopyridine derivatives as angiotensin II receptor antagonists
AU2230697A (en) Quinoxaline derivatives as glutamate receptor antagonists
GB9606489D0 (en) Fibrinogen receptor antagonists